Literature DB >> 2435928

Effects of calcium, calcium channel blockers and Bay K 8644 on contractions induced by muscarinic receptor stimulation of isolated bladder muscle from rabbit and man.

M Fovaeus, K E Andersson, S Batra, E Morgan, C Sjögren.   

Abstract

In isolated bladder smooth muscle from both rabbit and man, carbachol-induced contractions were reduced by the calcium channel blocker nifedipine, whereas the calcium channel promotor Bay K 8644 had no effect. In nominally calcium-free medium containing 10(-4) M EGTA, carbachol-induced contractions were reduced by 69% (rabbit) and 87% (man). These contractions were abolished by nifedipine, whereas Bay K 8644 significantly increased their amplitude, in rabbit preparations almost to control level. Electrical field stimulation produced contractions which could be suppressed by scopolamine by about 50% (rabbit) and more than 90% (man). These contractions were abolished by calcium-free medium (10(-4) M EGTA), suppressed by nifedipine, but significantly enhanced by Bay K 8644. The depressant effects of nifedipine, verapamil and diltiazem were reversed by Bay K 8644. The calcium channel blockers relaxed K+-induced contractions to base line, and this action was counteracted by Bay K 8644, less effectively when relaxations were induced by diltiazem. It is concluded that contractions produced by muscarinic receptor stimulation are primarily dependent on calcium bound to the outside of the membrane of the smooth muscle, and/or coming from the extracellular medium. Electrically evoked, scopolamine sensitive contractions seem to be mediated by a mechanism different from that of contractions produced by exogenously added muscarinic receptor agonist. The present data support the view that combined blockade of muscarinic receptors and calcium channels is an effective way of inhibiting bladder contractions in both rabbit and man.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435928     DOI: 10.1016/s0022-5347(17)44214-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Effects of pinacidil on bladder muscle.

Authors:  K E Andersson; P O Andersson; M Fovaeus; H Hedlund; A Malmgren; C Sjögren
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Effects of papaverine on human isolated bladder muscle.

Authors:  L Hertle; H Nawrath
Journal:  Urol Res       Date:  1990

3.  The contribution of intracellular Ca2+ release to contraction in human bladder smooth muscle.

Authors:  J G Masters; D E Neal; J I Gillespie
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Dependency of detrusor contractions on calcium sensitization and calcium entry through LOE-908-sensitive channels.

Authors:  J R Jezior; J D Brady; D I Rosenstein; K A McCammon; A S Miner; P H Ratz
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

5.  Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.

Authors:  J Latifpour; M Yoshida; R M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

6.  Effects of papaverine on tension and 45Ca-uptake in isolated urinary bladder.

Authors:  W Diederichs
Journal:  Urol Res       Date:  1991

7.  Comparison of Bay K 8644, nitrendipine and atropine on spontaneous and pelvic-nerve-induced bladder contractions on rat bladder in vivo.

Authors:  W Diederichs; J Sroka; J Graff
Journal:  Urol Res       Date:  1992

8.  Multiple sources of calcium for contraction of the human urinary bladder muscle.

Authors:  C A Maggi; S Giuliani; R Patacchini; D Turini; G Barbanti; A Giachetti; A Meli
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

9.  Muscarinic receptor-induced contractions of the detrusor are impaired in TRPC4 deficient mice.

Authors:  Caoimhin S Griffin; Keith D Thornbury; Mark A Hollywood; Gerard P Sergeant
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.